Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda (1993)
Chapter: B11. Primate Models for the Study of Antiprogestins in Reproductive Medicine
Unfortunately, this book can't be printed from the OpenBook.
If you need to print pages from this book, we recommend
downloading it as a PDF.
Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Previous Chapter:
B10. Uses of RU 486 as an Antiglucocoticoid
Next Chapter: B12. ANtiprogestogens: Perspectives from a Global Research Program
Suggested Citation:
"B11. Primate Models for the Study of Antiprogestins in Reproductive Medicine." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B11. Primate Models for the Study of Antiprogestins in Reproductive Medicine." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B11. Primate Models for the Study of Antiprogestins in Reproductive Medicine." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B11. Primate Models for the Study of Antiprogestins in Reproductive Medicine." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B11. Primate Models for the Study of Antiprogestins in Reproductive Medicine." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B11. Primate Models for the Study of Antiprogestins in Reproductive Medicine." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B11. Primate Models for the Study of Antiprogestins in Reproductive Medicine." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B11. Primate Models for the Study of Antiprogestins in Reproductive Medicine." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B11. Primate Models for the Study of Antiprogestins in Reproductive Medicine." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B11. Primate Models for the Study of Antiprogestins in Reproductive Medicine." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.